HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew J Mitcheltree Selected Research

iboxamycin

11/2021A synthetic antibiotic class overcoming bacterial multidrug resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthew J Mitcheltree Research Topics

Disease

1Gram-Negative Bacterial Infections
11/2021
1Carcinoma (Carcinomatosis)
04/2020
1Neoplasms (Cancer)
04/2020

Drug/Important Bio-Agent (IBA)

1iboxamycinIBA
11/2021
1Anti-Bacterial Agents (Antibiotics)IBA
11/2021
1Arginine (L-Arginine)FDA Link
04/2020
1ArginaseIBA
04/2020

Therapy/Procedure

1Immunotherapy
04/2020